News Release
USANA Schedules Fourth Quarter Earnings Release and Conference
Call
|
SALT
LAKE CITY--(BUSINESS WIRE)--Jan. 31, 2017-- USANA
Health Sciences, Inc. (NYSE:USNA)
today announced that fourth quarter and full-year results will be released
after the close of market Tuesday,
February 7, 2017. Shortly following the issuance of the Company’s earnings
release, the Company will post a “Management Commentary, Results and Outlook”
document on the Company’s website (www.usanahealthsciences.com) under the
“Investor Relations” section of the site. The following morning at 11:00 a.m. Eastern Time, USANA will
hold a conference call to discuss this announcement with analysts and
institutional investors. The call will consist of brief remarks by the
Company’s management team, before moving directly into questions and answers.
The
call will be broadcast over the Internet and can be accessed at http://www.usanahealthsciences.com.
The
webcast is also being distributed over Thomson’s Investor Distribution
Network to both institutional and individual investors. Individual investors
can listen to the call through Thomson’s individual investor center or by
visiting any of the investor sites in Thomson’s Individual Investor Network.
Institutional investors can access the call via Thomson’s password-protected
event management site, StreetEvents (www.streetevents.com).
About USANA
USANA
develops and manufactures high-quality nutritional supplements, healthy-food
and personal care products that are sold directly to Associates and Preferred
Customers throughout the United
States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Philippines, the Netherlands, the United Kingdom, Thailand, France, Belgium, Colombia and Indonesia. Additionally, USANA’s
wholly-owned subsidiary, BabyCare,
Ltd., operates a direct selling business in China.
More information on USANA can be found at http://www.usanahealthsciences.com.
View source version on
businesswire.com: http://www.businesswire.com/news/home/20170131005890/en/
Source: USANA Health Sciences, Inc.
USANA
Health Sciences, Inc.
Joshua Foukas, 801-954-7823 Investor Relations investor.relations@us.usana.com |